General
Preferred name
RIVOGLITAZONE
Synonyms
R-106056 ()
R 106056 ()
CS-011 ()
DE-101 ()
Rivoglitazona ()
P&D ID
PD004143
CAS
185428-18-6
Tags
available
drug candidate
Drug indication
Ocular inflammation
dry eye syndrome
Drug Status
experimental
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Rivoglitazone is a thiazolidinedione-derivative PPAR¦Ã agonist for the research of type 2 diabetes mellitus.
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
5
ChEMBL Drugs
DrugBank
DrugMAP
MedChem Express Bioactive Compound Library
ReFrame library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
20
Molecular Weight
397.11
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
1
Rotatable Bonds
6
Ring Count
4
Aromatic Ring Count
3
cLogP
3.06
TPSA
82.45
Fraction CSP3
0.25
Chiral centers
1.0
Largest ring
6.0
QED
0.69
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
PPAR
Pathway
Cell Cycle/DNA Damage
Metabolic Enzyme/Protease
Vitamin D Related/Nuclear Receptor
Source data
